Skip to main content
. 2022 Sep 26;50(2):613–621. doi: 10.1007/s00259-022-05970-y

Table 1.

Patients’ demographics

Age Median (IQR; range)
  Years 74 (70–78; 63–84)
PSA at baseline Median (IQR; range)
  ng/ml 49 (33–140; 15–5000)
S-testo at baseline Median (IQR; range)
  nmol/L 12 (7–17; 2–27)
Biopsy GGGa n (%)
  1 0 (0)
  2 0 (0)
  3 3 (12)
  4 4 (16)
  5 18 (72)
Clinical T-category n (%)
  cT1 0 (0)
  cT2 2 (8)
  cT3 19 (76)
  cT4 4 (16)

aGleason grade group